Trial Profile
A Multicentre, Open label, randomised, phase-IV study to evaluate the immunogenicity & safety of a single booster dose of BEs Tetanus Diphtheria (Td) vaccine (adsorbed) administered to healthy Indian children ≥7 years, Adolescents and Adults who received primary immunisation as compared with a marketed Diphtheria and Tetanus (Td) vaccine - None
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Apr 2019
Price :
$35
*
At a glance
- Drugs Diphtheria-tetanus vaccine (Primary)
- Indications Diphtheria; Tetanus
- Focus Pharmacodynamics
- Sponsors Biological E Limited
- 22 Jul 2014 New trial record